SL for fibromyalgia: if approved by FDA, TNX-102?SL would be the first new drug for fibromyalgia in more than 16?years? In?June?2025, the Company was ...

FDA PDUFA goal date of August 15, 2025, for TNX‑102 SL for fibromyalgia: if approved by FDA, TNX‑102 SL would be the first ...

Migraines are not just “bad headaches”; they are a complex neurological condition that can take different forms, often ...

Retinal conditions, like a detached retina or retinal vein occlusion, can also lead to sudden blurry vision in one eye, said ...

Silent migraines lack head pain but cause vision changes and dizziness. Numbness and speech issues can also occur. These ...

When we hear the word migraine, most of us immediately picture someone clutching their head in pain, hiding in a dark room.

Historically, sex-related differences have been underexplored in neurology. It is important to highlight the distinction ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

21."I have an extra artery supplying blood to my retina in each eye. It’s called a cilioretinal artery. If the main artery is ...

1."I don’t have B.O. when I sweat, and I've read it’s a genetic mutation. I don’t wear deodorant, and I’ve gone a whole 10 ...

SaveHealth reports migraines are complex neurological conditions affecting over a billion globally, requiring comprehensive understanding for effective treatment.

SaveHealth reports migraines are complex neurological conditions affecting over a billion globally, requiring comprehensive understanding for effective treatment.